| 1 |
30470150 | Nanocapsules embedded in microparticles for enhanced oral bioavailability and efficacy of Lopinavir as an anti-AIDS drug. | 2019 Jun - Jul |
1 |
| 2 |
27431863 | Alterations in P-Glycoprotein Expression and Function Between Macrophage Subsets. | 2016 Nov |
1 |
| 3 |
27543355 | Circumvention of P-gp and MRP2 mediated efflux of lopinavir by a histidine based dipeptide prodrug. | 2016 Oct 15 |
2 |
| 4 |
23528223 | Influence of MDR1 C1236T polymorphism on lopinavir plasma concentration and virological response in HIV-1-infected children. | 2013 Jun 10 |
1 |
| 5 |
20551216 | Protease inhibitors atazanavir, lopinavir and ritonavir are potent blockers, but poor substrates, of ABC transporters in a broad panel of ABC transporter-overexpressing cell lines. | 2010 Aug |
1 |
| 6 |
19757141 | Paralytic ileus possibly associated with interaction between ritonavir/lopinavir and vincristine. | 2009 Dec |
1 |
| 7 |
18455890 | Peptide prodrugs: improved oral absorption of lopinavir, a HIV protease inhibitor. | 2008 Jul 9 |
2 |
| 8 |
18692133 | Emtricitabine: Inhibitor and substrate of multidrug resistance associated protein. | 2008 Nov 15 |
1 |
| 9 |
19002102 | Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir. | 2008 Nov |
1 |